TANVIR QURESHI, MD PC
Specialist in MONROE, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
TANVIR QURESHI, MD PC filed 7,274 Medicare Part D claims in 2023 as a Specialist in MONROE, Michigan, prescribing 91% generic.
- 7K
- Part D claims, 2023
- 91%
- generic prescribing
- $177.29
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
TANVIR QURESHI, MD PC's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
7,274 Top 3% higher than 97% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about TANVIR QURESHI, MD PC?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Michigan
How Specialist compares to other specialties among Michigan providers
Specialist share within Michigan
Specialist is one of the more visible NUCC categories in Michigan
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Specialist ABMS/AOA estimate
Est. board-certified rate (Specialist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Specialist US NPIs
Specialty board-certified rate — Specialist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
TANVIR QURESHI, MD PC appears in the CMS NPPES registry as a Specialist provider holding MD PC credentials at 5290 W. BROOKSHIRE COURT, MONROE, MI, 48161, with a listed phone of (734) 242-5544. NPI 1447253760 was issued on 05/31/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what QURESHI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 7,274 prescription claims written by this provider, covering 358 Medicare beneficiaries and totaling roughly $528K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 6.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1447253760 |
|---|---|
| Specialty | Specialist |
| Credentials | MD PC |
| Gender | Male |
| NPI Issued | 05/31/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm TANVIR QURESHI, MD PC's current license status, disciplinary history, and board certifications with the Michigan Department of Licensing and Regulatory Affairs in Michigan before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TANVIR QURESHI, MD PC. Source: openpaymentsdata.cms.gov.
Total received
$177
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Michigan MI-BOM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to TANVIR QURESHI, MD PC. To verify TANVIR QURESHI, MD PC's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 7,274 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 12,582
- Total Day Supply
- 356,000
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $421K
- Generic Drug Cost
- $102K
- Opioid Claims
- 444 (6.1% rate)
- Antibiotic Claims
- 408
Patient Demographics
- Average Patient Age
- 70.5 years
- Avg HCC Risk Score
- 1.14
- Gender Split
- 54% female / 46% male
- Age Distribution
- <65: 82, 65-74: 162, 75-84: 89, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What TANVIR QURESHI, MD PC prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisone
Prednisone
406 claims
- Alprazolam
Alprazolam
401 claims
- Metoprolol Tartrate
Metoprolol Tartrate
351 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
315 claims
- Pantoprazole Sodium
Pantoprazole Sodium
268 claims
- Meloxicam
Meloxicam
172 claims
- Omeprazole 158
Omeprazole
158 claims
- Levothyroxine Sodium 151
Levothyroxine Sodium
151 claims
| Drug | Claims |
|---|---|
| Prednisone | 406 |
| Alprazolam | 401 |
| Metoprolol Tartrate | 351 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 315 |
| Pantoprazole Sodium | 268 |
| Meloxicam | 172 |
| Omeprazole | 158 |
| Levothyroxine Sodium | 151 |
| Ibuprofen | 146 |
| Atorvastatin Calcium | 143 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How TANVIR QURESHI, MD PC fits within the Specialist landscape nationally.
TANVIR QURESHI, MD PC's 7,274 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as QURESHI.
Compare Specialist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Michigan
Frequently Asked Questions
What is TANVIR QURESHI, MD PC's specialty? ▼
How much does TANVIR QURESHI, MD PC prescribe under Medicare Part D? ▼
Where is TANVIR QURESHI, MD PC located? ▼
What is TANVIR QURESHI, MD PC's NPI number? ▼
Does TANVIR QURESHI, MD PC prescribe more brand-name or generic drugs? ▼
Does TANVIR QURESHI, MD PC prescribe opioids? ▼
How many Specialist providers are there in the US? ▼
What drugs does TANVIR QURESHI, MD PC prescribe most often? ▼
Does TANVIR QURESHI, MD PC accept Medicare? ▼
How can I verify TANVIR QURESHI, MD PC's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology